Your browser doesn't support javascript.
loading
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
Eshleman, S H; Krogstad, P; Jackson, J B; Wang, Y G; Lee, S; Wei, L J; Cunningham, S; Wantman, M; Wiznia, A; Johnson, G; Nachman, S; Palumbo, P.
Affiliation
  • Eshleman SH; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA. seshlem@jhmi.edu
J Infect Dis ; 183(12): 1732-8, 2001 Jun 15.
Article in En | MEDLINE | ID: mdl-11372025
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Reverse Transcriptase Inhibitors / Anti-HIV Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Infect Dis Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Reverse Transcriptase Inhibitors / Anti-HIV Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Infect Dis Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States